Atópiás dermatitisz (ekcéma): vizsgálatok itt: Spanyolország
20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Alicante, Fuenlabrada, Madrid, Valencia
- Életkor
- 6 hónap to 11 év
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - 3. fázisNot yet taking people in SpanyolországA Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
- Where
- Alicante, Badalona, Bilbao, Las Palmas De Gran Canaria, Madrid, Santiago de Compostela
- People
- 150 worldwide
- Run by
- Hunan Mabgeek Biotech Co. Ltd.
See details and how to join2025-525022-35-00 · EU 2025-525022-35-00 - 3. fázisTaking peopleA Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Where
- Granollers, Santiago de Compostela, Zaragoza
- Életkor
- 2 év to 11 év
- People
- 450 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00 - 2. fázisTaking peopleA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Where
- Alicante, Badalona, Las Palmas de Gran Canaria, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Apogee Therapeutics, Inc.
See details and how to joinNCT07003425 - No phaseTaking peopleThis Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Where
- Alicante, Barcelona, Santa Cruz de Tenerife
- Életkor
- 12 év and over
- People
- 1000 worldwide
- Run by
- Sanofi
See details and how to joinNCT07290803 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
- Where
- Alicante, Badalona, Madrid, Santiago de Compostela, Zaragoza
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Apollo Therapeutics Limited
See details and how to join2026-525673-39-00 · EU 2026-525673-39-00 - 3. fázisCsak meghívásosA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Barcelona, Las Palmas de Gran Canaria, Madrid, Manises, Pamplona, Pontevedra, Pozuelo de Alarcón
- Életkor
- 6 hónap to 18 év
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Alicante, Bilbao, Burjassot, Granada, Madrid, Málaga, Sevilla, Valencia
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00 - 3. fázisNot yet taking people in SpanyolországA Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
- Where
- Alicante, Badalona, Barcelona, Bilbao, Granada, Granollers, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Madrid, Majadahonda, Málaga, Palma, Pontevedra, Salamanca, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- 12 év and over
- People
- 230 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00 - 2. fázisNot yet taking people in SpanyolországA study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis
- Where
- Alicante, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Enveda Therapeutics Inc.
See details and how to join2026-526184-38-00 · EU 2026-526184-38-00 - 2. fázisTaking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Alicante, Badalona, Granada, Las Palmas De Gran Canaria, Madrid, Pontevedra
- Életkor
- 18 év to 100 év
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - 3. fázisTaking peopleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Where
- Granollers, Santiago de Compostela, Zaragoza
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807268 · EU 2023-509121-51-00 - 1. fázisTaking peopleA Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
- Where
- Barcelona
- Életkor
- 18 év to 64 év
- People
- 291 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 · EU 2025-523826-41-00 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Alicante, Badalona, La Paz, Santiago de Compostela, Zaragoza
- Életkor
- 18 év to 65 év
- People
- 280 worldwide
- Run by
- Apollo Therapeutics Ltd
See details and how to joinNCT07599813 - 2. fázisTaking peopleA Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
- Where
- Alicante, Badalona, Las Palmas De Gran Canaria, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- Apogee Therapeutics Inc.
See details and how to join2024-519795-11-00 · EU 2024-519795-11-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Barcelona, Córdoba, Granollers, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Madrid, Manises, Santiago de Compostela, Zaragoza
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00 - No phaseTaking peopleEffect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
- Where
- A Coruña, Almería, Barcelona, Madrid, Málaga, Seville, Tarragona, Zaragoza
- Életkor
- 1 nap to 14 nap
- People
- 400 worldwide
- Run by
- Société des Produits Nestlé (SPN)
See details and how to joinNCT06943469 - 2. fázisTaking peopleStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD
- Where
- Alicante, Burjassot, Granada, Málaga, Manises, Mieres, Sevilla
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00 - 4. fázisTaking peopleOptimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment response (DermAtOmics-II)
- Where
- Madrid
- Run by
- Hospital Universitario La Paz
See details and how to join2023-506165-62-00 · EU 2023-506165-62-00 - No phaseTaking peopleSpanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy
- Where
- Alicante, Badalona, Barcelona, Las Palmas, Madrid, Pontevedra, Valencia, Zaragoza
- People
- 2500
- Run by
- Fundación Academia Española de Dermatología
See details and how to joinNCT05674695